MARKET

SHC

SHC

Sotera Health Co
NASDAQ

Real-time Quotes | Nasdaq Last Sale

27.06
-0.91
-3.25%
Closed 16:00 11/30 EST
OPEN
28.10
PREV CLOSE
27.97
HIGH
28.34
LOW
26.89
VOLUME
932.94K
TURNOVER
--
52 WEEK HIGH
29.00
52 WEEK LOW
24.05
MARKET CAP
7.50B
P/E (TTM)
-328.7971
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
December Will Be The Big IPO Finale Of 2020
We are getting close to the end of 2020. It's been a year like no other, the year where everything was in the shade of a global pandemic.
Benzinga · 5d ago
The Daily Biotech Pulse: Revance's DAXI Regulatory Decision, Reata Slips On FDA Feedback, Liquidia Setback
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 24)
Benzinga · 5d ago
Sotera Health Announces Closing of Initial Public Offering
CLEVELAND, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) today announced the closing of its initial public offering (“IPO”) of 53,590,000 shares of its common stock at a public offering price of $23.00 per share, for gross proceeds of approximately $1.2 billion, before deducting underwriting discounts and commissions and offering expenses. J.P. Morgan, Credit Suisse, Goldman Sachs & Co. LLC and Jefferies acted as joint lead book-running managers and as representatives of the underwriters for the offering. Barclays, Citigroup and RBC Capital Markets acted as joint book-running managers for the offering. BNP PARIBAS, KeyBanc Capital Markets, Citizens Capital Markets, ING, Academy Securities, Loop Capital Markets, Penserra Securities LLC, Siebert Williams Shank and Tigress Financial Partners acted as co-managers for the offering.The offering was made only by means of a prospectus. Copies of the final prospectus relating to the offering may be obtained from: J.P. Morgan Securities, LLC, Attention: Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at 1-866-803-9204 or by email at prospectus-eq_fi@jpmchase.com; Credit Suisse Securities (USA), LLC, Attention: Prospectus Department, 6933 Louis Stephens Drive, Morrisville, NC 27560, by telephone at (800) 221-1037, or by email at usa.prospectus@credit-suisse.com; Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, NY 10282, by telephone 1-866- 471-2526 or by email at Prospectus-ny@ny.email.gs.com; or Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, 2nd Floor, New York, NY 10022, by telephone 1-877-821-7388 or by email at Prospectus_Department@Jefferies.com.A registration statement relating to these securities was declared effective as of November 19, 2020 by the Securities and Exchange Commission.This press release shall not constitute an offer to sell, or the solicitation of an offer to buy these securities, nor shall there be any sale of, these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.Forward-looking Statement:Statements in this press release regarding the Company that are not historical facts are “forward-looking statements” that involve risks and uncertainties. Certain of these risks and uncertainties are described in the Company's registration statement on Form S-1 filed with the SEC, including under the headings of "Risk Factors" and "Cautionary Note Regarding Forward-Looking Statements" in the registration statement. Forward-looking statements made in this release speak only as of the date of this release, and the Company undertakes no obligation to update the information contained in this press release to reflect subsequently occurring events or circumstances, except as required by law.About Sotera Health:Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses – Sterigenics®, Nordion® and Nelson Labs®. Sotera Health is committed to its mission, Safeguarding Global Health®.CONTACTS:     Sally J. Curley, IRCJenny Kobin Curley Global IR, LLCIR Advisory Solutions IR@soterahealth.com IR@soterahealth.com     Kristin Gibbs  Chief Marketing Officer, Sotera Health  kgibbs@soterahealth.com      Source: Sotera Health Company
GlobeNewswire · 6d ago
The Daily Biotech Pulse: Alnylam's Oxluma Snags Early FDA Approval, DBV Chief Scientific Officer To Depart, Decision Day For Liquidia
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 23)
Benzinga · 6d ago
Last Week's IPO Recap
Last week brought us six new IPOs. Among these, breast cancer biotech company Olema Pharmaceuticals (NASDAQ: OLMA) led the way as the week's top performer while its stock skyrocketed 157% on its first day. Olema Pharmaceuticals was the only one to hurry up and go public before the holiday.
Benzinga · 11/23 17:45
Sotera Health IPO Prices At High End Of Range; Shares Surge
Investor's Business Daily · 11/20 21:18
Maravai IPO Raises $1.62 Billion For Provider Of Drug-Testing Services
Investor's Business Daily · 11/20 21:17
Maravai LifeSciences, Sotera Are Slated to Trade Today
Both companies are backed by GTCR, the Chicago buyout shop. IPOs came back this week following a pause for the presidential election.
Barrons.com · 11/20 17:12
More
Forecast
EPSBVPSCFPS
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of SHC. Analyze the recent business situations of Sotera Health Co through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About SHC
Sotera Health Company., is a medical device company. The Company is a provider of sterilization and lab testing and advisory services to the medical device and pharmaceutical industries. The Company has three segments: Sterigenics, Nordion and Nelson Labs. It focuses on sterilization services and lab services. The Sterilization Services includes products, such as medical protective barriers, including personal protective equipment, procedure kits and trays, catheters, wound care products, laboratory products and pharmaceuticals. The lab services offer microbiology testing services, analytical chemistry lab testing and advisory services. Medical device lab testing services include microbiology, biocompatibility and toxicology assessments, sterility assurance, packaging validation and distribution simulation, and reprocessing validations. The pharmaceutical lab testing services include microbiology, biocompatibility and toxicology assessments, extractables and sterilization validation.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Sotera Health Co stock information, including NASDAQ:SHC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SHC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SHC stock methods without spending real money on the virtual paper trading platform.